David M. Knott Jr’s Madrigal Pharmaceuticals MDGL Stock Holding History

David M. Knott Jr’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.61M	Buy	3,000 +1,000	+50%	+$512K	0.85%	24
2026 Q1	$1.05M	Hold	2,000	–	–	0.62%	33
2025 Q4	$1.16M	Hold	2,000	–	–	0.54%	31
2025 Q3	$917K	Hold	2,000	–	–	0.37%	37
2025 Q2	$605K	Buy	+2,000	New	+$596K	0.27%	46
2024 Q2	–	Sell	-3,584	Closed	-$957K	–	107
2024 Q1	$957K	Sell	3,584 -11,216	-76%	-$2.64M	0.34%	44
2023 Q4	$3.42M	Sell	14,800 -200	-1%	-$35K	1.31%	15
2023 Q3	$2.19M	Buy	15,000 +1,000	+7%	+$188K	0.84%	22
2023 Q2	$3.23M	Hold	14,000	–	–	1.29%	16
2023 Q1	$3.39M	Buy	14,000 +6,000	+75%	+$1.63M	1.33%	15
2022 Q4	$2.32M	Buy	8,000 +7,000	+700%	+$685K	0.88%	25
2022 Q3	$65K	Buy	+1,000	New	+$69.5K	0.03%	104

Other funds holding MDGL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

David M. Knott Jr's MDGL Position: Q2 2026 in Review

David M. Knott Jr increased its Madrigal Pharmaceuticals (MDGL) stake by 50% in Q2 2026, buying an estimated $512K and bringing the position to 3,000 shares worth $1.61M. The position accounts for 0.85% of the portfolio, ranked #24.

David M. Knott Jr first reported a position in MDGL in Q3 2022 and has held it in 12 quarters since. The position peaked at $3.42M in Q4 2023. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

David M. Knott Jr held 3,000 shares of Madrigal Pharmaceuticals worth $1.61M as of Q2 2026.
David M. Knott Jr bought 1,000 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $512K.
Madrigal Pharmaceuticals made up 0.85% of David M. Knott Jr's portfolio in Q2 2026, its #24 holding.
David M. Knott Jr first reported a position in Madrigal Pharmaceuticals in Q3 2022 and has held it in 12 quarters since.
David M. Knott Jr's Madrigal Pharmaceuticals position peaked at $3.42M in Q4 2023.
413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on David M. Knott Jr's 13F filing for Q2 2026, filed 12 Aug 2026.